Navigation Links
Intra-Cellular Therapies Cleared for Quotation on OTCQB
Date:12/19/2013

molecule in the ITI/Takeda collaboration, ITI-214.  The Company has additional programs in the areas of Parkinson's disease, Alzheimer's disease, depression and cardiovascular disease.

Forward-looking Statements

This news release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. Such forward-looking statements include statements regarding, among other things, the expected timing of the commencement of trading on the OTCQB of our common stock, the results of our Phase 2 clinical trial of ITI-007 in patients with acutely exacerbated schizophrenia, and our research and development efforts and plans under the caption "About Intra-Cellular Therapies." All such forward-looking statements are based on management's present expectations and are subject to certain factors, risks and uncertainties that may cause actual results, outcome of events, timing and performance to differ materially from those expressed or implied by such statements. These risks and uncertainties include, but are not limited to the following: our current and planned clinical trials for ITI-007 and our other product candidates may not be successful or may take longer and be more costly than anticipated;  product candidates that appeared promising in early research and clinical trials may not demonstrate safety and/or efficacy in larger-scale or later clinical trials; our reliance on collaborative partners and other third-parties for further clinical trials, development and commercialization of our product candidates; the costs associated with our research, development and other activities may exceed those that we estimate; the conduct and results of preclinical and clinical studies of our product candidates may pose ch
'/>"/>

SOURCE Intra-Cellular Therapies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Intra-Cellular Therapies Announces Closing of $60 Million Private Placement and Completion of Reverse Merger
2. Intra-Cellular Therapies Announces Completion of Phase I Single Rising Dose Trial of First-in-Class Selective Phosphodiesterase 1 (PDE1) Inhibitor and Reports Top-line Safety and Pharmacokinetic Findings
3. Immunotherapies Will Continue to Dominate the Malignant Melanoma Drug Market with Sales of Immune Checkpoint Inhibitors Accounting for Majority of Sales in this Drug Class in 2022
4. The Leukemia & Lymphoma Societys (LLS) Greater Bay Area Chapter to Host the 2014 Emerging Therapies & Survivorship Conference
5. Sangamo BioSciences Presents Data From Non-Human Primates Providing Proof Of Concept For Disruptive And Broadly Leverageable Platform For Protein Replacement Therapies
6. Improved Efficacy, Limited Toxicity of Targeted Therapies Brighten the Future of Treatment for Chronic Lymphocytic Leukemia
7. Innovative Compounds, Combination Therapies Improve Care of Patients with Wide Range of Blood Disorders
8. Study Confirms Efficacy of Innovative Therapies Quantum Negative Pressure Wound Therapy (NPWT) in Enhancing Wound Healing
9. Contrasting Reimbursement Environments Result in Different Prescribing Patterns for Premium-Priced Therapies in China and South Korea
10. U.S. Claims Data Show Declining Use of Platform Injectables as Oral Multiple Sclerosis Therapies Gain Traction
11. In the Psoriasis Drug Market, Continued Uptake of Janssens Stelara and the Launch of Emerging Systemic Therapies Will Drive Sales Growth to Nearly $9.2 Billion in 2022
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Aug. 28, 2014 Tianyin Pharmaceutical ... a pharmaceutical company that specializes in patented biopharmaceutical, ... active pharmaceutical ingredients (API) today updates the timeline ... Facility (QLF). The Company is ... dataset for China Food & Drug Administration,s (CFDA) ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- Academy Leadership, ... service academy graduates, has published a case study ... Leadership Excellence Course . In September and October ... Course to Albuquerque , Indianapolis , ... Photo - http://photos.prnewswire.com/prnh/20140828/140814 ...
(Date:8/28/2014)... Aug. 28, 2014 Nonin Medical, Inc., the ... noninvasive medical monitoring, today announced that the Food and ... OEM/eHealth finger pulse oximeter for use in ... plugs into a telemedicine hub or kiosk through a ... in pediatric to adult patients. The Model 3231 received ...
Breaking Medicine Technology:TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5Nonin Medical Announces FDA Clearance of Nonin Model 3231 USB Pulse Oximeter 2
... 10, 2011 Key Equipment Finance , one ... an affiliate of KeyCorp (NYSE: KEY ) ... exclusive, long term, program agreement with Hitachi Medical ... U.S. distributor of Hitachi Medical Corporation,s diagnostic imaging products. ...
... Jan. 7, 2011 Questcor Pharmaceuticals, Inc. (Nasdaq: ... Annual J.P. Morgan Healthcare Conference has been rescheduled for 9:00 ... St. Francis Hotel in San Francisco. Questcor was originally scheduled ... 2011. Don M. Bailey, President and Chief Executive Officer, will ...
Cached Medicine Technology:Key Equipment Finance Enters Long-Term Program Agreement With Hitachi Medical Systems America 2Key Equipment Finance Enters Long-Term Program Agreement With Hitachi Medical Systems America 3
(Date:8/28/2014)... HORNE LLP has laid out the ... The $67 million firm has more than feel-good emotions ... in the balance. , Described by experts in the ... of Baby Boomers creating succession issues, poor leadership development ... creating culture wars within firms that are threatening the ...
(Date:8/28/2014)... third of women who are given information about the ... may not fully understand the risks involved, according to ... (BJC) , today (Friday). , In a survey of ... College London (UCL) found that 64 per cent felt ... the chance that screening will pick up cancers that ...
(Date:8/28/2014)... Worth, FL (PRWEB) August 28, 2014 ... National Recovery Month throughout September. This month will ... addiction treatment and mental health services. Along with ... Treatment Group is helping to spread the word ... began in 1989, honoring the work of treatment ...
(Date:8/28/2014)... 2014 Millennium Treatment Group has noticed ... the workplace. A recent report from the National ... that drug abuse is costing employers an estimated $81 ... addicted to drugs affect their employers and the company ... the workplace, causing expensive problems for their employers, such ...
(Date:8/28/2014)... HealthDay Reporter THURSDAY, Aug. 28, ... may worsen symptoms of multiple sclerosis (MS), a new study ... as vitamin D, smoking and Epstein Barr virus infection. Our ... factor affecting MS patients," said lead researcher Dr. Mauricio Farez, ... Aires. Multiple sclerosis is a disease of the nervous ...
Breaking Medicine News(10 mins):Health News:HORNE LLP Proclaims War on Accounting Firm Culture 2Health News:Some women still don't underststand 'overdiagnosis' risk in breast screening 2Health News:Millennium Treatment Group Celebrates National Recovery Month 2Health News:Drug Use Causes Problems in the Workplace 2Health News:Could Too Much Salt Harm MS Patients? 2Health News:Could Too Much Salt Harm MS Patients? 3
... Reporter , THURSDAY, March 3 (HealthDay News) -- More young ... men are engaging in same-sex encounters, according to a new ... statistics compiled from interviews with 13,500 men and women aged ... also indicates that more than half of young people under ...
... will hold its 111th General Meeting May 21-24, ... will feature approximately 3,000 individual scientific presentations spanning ... attendance of 10,000. Microbiologists study living organisms ... to human and animal health, agriculture, the environment ...
... 3 (HealthDay News) -- The brain,s so-called reward center actually ... experiences causing fear, finds a new study in mice. ... may help explain why some people are thrill-seekers. Pleasurable ... off a bridge, can trigger the production of dopamine, a ...
... HealthDay Reporter , THURSDAY, March 3 (HealthDay News) -- A new ... a position thought to pose a risk for SIDS -- have ... on their backs. The discovery suggests that a lack of ... at a higher risk of sudden infant death syndrome while sleeping: ...
... Medicine have discovered that a natural product isolated from a ... or lei gong teng, and used for hundreds of years ... gene control machinery in the cell. The report, published as ... Chemical Biology, suggests that the natural product could be ...
... Unexpected results from a Scripps Research Institute and ModGene, ... to the liver instead of the brain as the source ... with this devastating condition. The findings could offer a relatively ... was published online today in The Journal of Neuroscience ...
Cached Medicine News:Health News:More Young People Delay Sex, Try Oral Sex First, CDC Says 2Health News:More Young People Delay Sex, Try Oral Sex First, CDC Says 3Health News:American Society for Microbiology to host 111th General Meeting in New Orleans 2Health News:Research Uncovers Clue to SIDS 2Health News:Solving a traditional Chinese medicine mystery 2Health News:Solving a traditional Chinese medicine mystery 3Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 2Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 3Health News:Scripps Research study points to liver, not brain, as origin of Alzheimer's plaques 4
PDA application containing all 7,000+ Physicians' Current Procedural Terminology codes developed by the American Medical Association....
PDA application contains 15,000+ ICD-9-CM Diagnosis codes....
Contains the most common procedures from all orthopedic sub-specialties organized by body area....
Athouritative, on the spot answers for acute care and consultations....
Medicine Products: